Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

AgeX Therapeutics Q2 EPS $(0.07), Same YoY, Sales $9.00K Down From $12.00K YoY

Author: Benzinga Newsdesk | August 14, 2023 05:09pm
AgeX Therapeutics (AMEX:AGE) reported quarterly losses of $(0.07) per share. This is unchanged from the same period last year. The company reported $9.00 thousand in sales this quarter. This is a 25.00 percent decrease over sales of $12.00 thousand the same period last year.

Posted In: AGE


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist